MedPath

A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China

Conditions
Breast Cancer
Registration Number
NCT02493569
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Brief Summary

The purpose of the study is to study the epidemic features and diagnosis of female breast cancer, especially the diagnosis and treatment of breast cancer.The disease-free survival (DFS) and the total survival time(OS) of the breast cancer patients will also be studied.

Detailed Description

The study is a multicentric, retrospective clinical study based on the hospital. The target number of cases are X patients who are eligible for breast cancer after radical mastectomy. To collect the clinicopathological data and treatment data of the breast cancer patients and do the follow-up visit of all the patients who are included in the study.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
3000
Inclusion Criteria
  • Female patients;
  • The hospitalized patients who are confirmed of the primary breast cancer histologically;
  • The date of the inpatients are within the month we chosen;
  • Patients who are within the month we chosen have been received or under receiving the relevant treatment including surgical treatment, chemotherapy and radiotherapy.
Exclusion Criteria
  • Male breast cancer patients;
  • Patients with breast cancer who are not under the chosen time;
  • Non hospitalized patients.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall five-year survival for the female breast cancer patients5 years
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.